Dr John Manion, MD | |
3435 West Broadway, Suite 1065, Robbinsdale, MN 55422 | |
(763) 520-1137 | |
(763) 520-1976 |
Full Name | Dr John Manion |
---|---|
Gender | Male |
Speciality | Internal Medicine - Hematology & Oncology |
Location | 3435 West Broadway, Robbinsdale, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073605952 | NPI | - | NPPES |
373005 | Other | MN | PREFERRED ONE |
0413229 | Other | MN | MEDICA |
0413229 | Other | MN | SELECT CARE |
101041 | Other | MN | UCARE |
4T905MA | Other | MN | BLUE CROSS BLUE SHIELD |
A94694 | Other | MN | HEALTH PARTNERS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 17358 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John Manion, MD 3435 West Broadway, Suite 1065, Robbinsdale, MN 55422 Ph: (763) 520-1137 | Dr John Manion, MD 3435 West Broadway, Suite 1065, Robbinsdale, MN 55422 Ph: (763) 520-1137 |
News Archive
By our first birthday, we've acquired over 400 bacterial passengers in our gastrointestinal tract. Our gut microbes, or "bugs," work to keep our complex and diverse gut ecosystem in balance. Unfortunately, the trials of daily life-stressful events, aging, diet, or immune challenges-can be hard on these bugs. Standard Process Inc. introduces a new product, ProSynbiotic, to help our body maintain a healthy, balanced gut ecosystem.
A study in Norway suggests echocardiographic screening in the general public for structural and valvular heart disease was not associated with benefit for reducing the risk of death, myocardial infarction (heart attack) or stroke, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
Combining the latest methods in gene splicing and computer modeling, Rice University researchers are trying to develop a predictive framework for one of the most basic and complex biological phenomena — cellular heterogeneity, or the ability of genetic clones to act and behave differently when exposed to the same set of environmental stimuli.
The phase 3 AVERROES (Apixaban Versus Acetylsalicylic acid (ASA) to Prevent Strokes) trial, designed to show the superiority of apixaban over aspirin for the prevention of stroke or systemic embolism in high-risk atrial fibrillation patients unsuitable for treatment with a vitamin K antagonist (warfarin), was terminated early following a recommendation from the Data Monitoring Committee.
› Verified 8 days ago
Dr. Alok Maheshwari, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 763-581-5400 Fax: 763-581-5401 | |
Ethan Michael Fruechte, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3300 Oakdale Ave N, Suite 200, Robbinsdale, MN 55422 Phone: 763-581-5400 Fax: 763-520-2099 | |
Matthew Nolan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3366 Oakdale Ave N Ste 401, Robbinsdale, MN 55422 Phone: 763-520-2940 | |
Jerrold Martin Stempel, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3366 Oakdale Ave N, Suite 315, Robbinsdale, MN 55422 Phone: 763-520-7900 Fax: 763-520-7989 | |
Chike Uchenna Anthony Obi, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 763-581-5400 Fax: 763-581-5401 | |
Andrew Joob, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 763-520-5200 |